Variants in FSHB are associated with polycystic ovary syndrome and luteinizing hormone level in Han Chinese Women

Journal of Clinical Endocrinology and Metabolism

Volumn 101, Issue 5, 2016, Pages 2178-2184

  Tian, Ye ^a,b,c,d,e   Zhao, Han ^c,d,e   Chen, Haitao ^f   Peng, Yingqian ^c,d,e   Cui, Linlin ^c,d,e   Du, Yanzhi ^a,b   Wang, Zhao ^c,d,e   Xu, Jianfeng ^f,g   Chen, Zi Jiang ^a,b,c,d,e  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shanghai Key Laboratory of Assisted Reproduction and Reproductive Genetics   (China)

^c SHANDONG UNIVERSITY   (China)

^d BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^e Shandong Provincial Key Laboratory of Reproductive Medicine   (China)

^f FUDAN UNIVERSITY   (China)

^g NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUTEINIZING HORMONE; FOLLITROPIN BETA SUBUNIT; GLYCOPROTEIN; YOUNG AGE-RELATED GLYCOPROTEIN, HUMAN;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD LEVEL; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE MARKER; DISEASE PREDISPOSITION; FEMALE; FOLLICLE STIMULATING HORMONE B POLYPEPTIDE GENE; GENE; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENOTYPE; HAN CHINESE; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CASE CONTROL STUDY; CHINA; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY;

ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; FEMALE; FOLLICLE STIMULATING HORMONE, BETA SUBUNIT; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GLYCOPROTEINS; HUMANS; LUTEINIZING HORMONE; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84969752514     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-3776     Document Type: Article

References (27)

1. Li R, Zhang Q, Yang D, et al. Prevalence of polycystic ovary syndrome in women in China: A large community-based study. Hum Reprod. 2013;28:2562-2569.
2. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41-47.
3. Franks S. Polycystic ovary syndrome. N Engl J Med. 1995;333:853-861.
4. Moran LJ, Misso ML, Wild RA, Norman RJ. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: A systematic review and meta-analysis. Hum Reprod Update. 2010;16:347-363.
5. Lim SS, Davies MJ, Norman RJ, Moran LJ. Overweight, obesity and central obesity in women with polycystic ovary syndrome: A systematic review and meta-analysis. Hum Reprod Update. 2012;18:618-637.
6. Wild RA, Rizzo M, Clifton S, Carmina E. Lipid levels in polycystic ovary syndrome: Systematic review and meta-analysis. Fertil Steril. 2011;95:1073-1079. e1071-e1011.
7. Azziz R. Polycystic ovary syndrome is a family affair. J Clin Endocrinol Metab. 2008;93:1579-1581.
8. Vink JM, Sadrzadeh S, Lambalk CB, Boomsma DI. Heritability of polycystic ovary syndrome in a Dutch twin-family study. J Clin Endocrinol Metab. 2006;91:2100-2104.
9. Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: Etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011;7:219-231.
10. Chen ZJ, Zhao H, He L, et al. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet. 2011;43:55-59.
11. Shi Y, Zhao H, Shi Y, et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat Genet. 2012;44:1020-1025.
12. Brower MA, Jones MR, Rotter JI, et al. Further investigation in europeans of susceptibility variants for polycystic ovary syndrome discovered in genome-wide association studies of Chinese individuals. J Clin Endocr Metab. 2015;100:E182-E186.
13. Welt CK, Styrkarsdottir U, Ehrmann DA, et al. Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry. J Clin Endocr Metab. 2012;97:E1342-E1347.
14. Louwers YV, Stolk L, Uitterlinden AG, Laven JS. Cross-ethnic meta-analysis of genetic variants for polycystic ovary syndrome. J Clin Endocr Metab. 2013;98:E2006-E2012.
15. Mutharasan P, Galdones E, Peñalver Bernabé BP, et al. Evidence for chromosome 2p16.3 polycystic ovary syndrome susceptibility locus in affected women of European ancestry. J Clin Endocr Metab. 2013;98:E185-E190.
16. Goodarzi MO, Jones MR, Li X, et al. Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts. J Med Genet. 2012;49:90-95.
17. Hayes MG, Urbanek M, Ehrmann DA, et al. Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations. Nat Commun. 2015;6.
18. Shi Y, Guo M, Yan J, et al. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome. Neuro Endocrinol Lett. 2007;28:807-810.
19. Fan QR, Hendrickson WA. Structure of human follicle-stimulating hormone in complex with its receptor. Nature. 2005;433:269-277.
20. Meduri G, Bachelot A, Cocca MP, et al. Molecular pathology of the FSH receptor: New insights into FSH physiology. Mol Cell Endocrinol. 2008;282:130-142.
21. McGee EA, Hsueh AJ. Initial and cyclic recruitment of ovarian follicles. Endocr Rev. 2000;21:200-214.
22. Kauffman AS, Thackray VG, Ryan GE, et al. A novel letrozole model recapitulates both the reproductive and metabolic phenotypes of polycystic ovary syndrome in female mice. Biol Reprod. 2015;93:69.
23. Catteau-Jonard S, Jamin SP, Leclerc A, Gonzales J, Dewailly D, di Clemente N. Anti-Mullerian hormone, its receptor, FSH receptor, and androgen receptor genes are overexpressed by granulosa cells from stimulated follicles in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2008;93:4456-4461.
24. Hoogendoorn B, Coleman SL, Guy CA, et al. Functional analysis of human promoter polymorphisms. Hum Mol Genet. 2003;12:2249-2254.
25. Grigorova M, Punab M, Ausmees K, Laan M. FSHB promoter polymorphism within evolutionary conserved element is associated with serum FSH level in men. Hum Reprod. 2008;23:2160-2166.
26. Eagleson CA, Gingrich MB, Pastor CL, et al. Polycystic ovarian syndrome: Evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J Clin Endocr Metab. 2000;85:4047-4052.
27. Kumar TR, Wang Y, Lu N, Matzuk MM. Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nat Genet. 1997;15:201-204.